 | Atara Biotherapeutics to Participate at Two Upcoming Investor Conferences
finance.yahoo.com - February 20 at 6:33 PM |
 | Atara Biotherapeutics (ATRA) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - February 20 at 9:53 AM |
| Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020
finance.yahoo.com - February 19 at 5:23 PM |
| Atara Biotherapeutics (NASDAQ:ATRA) Earns Buy Rating from Canaccord Genuity
www.americanbankingnews.com - February 18 at 7:43 AM |
| Insider Selling: Atara Biotherapeutics Inc (NASDAQ:ATRA) CFO Sells 1,781 Shares of Stock
www.americanbankingnews.com - February 10 at 9:02 PM |
| Atara Biotherapeutics Inc (NASDAQ:ATRA) Insider Joe Newell Sells 4,117 Shares
www.americanbankingnews.com - February 10 at 9:02 PM |
| Atara Biotherapeutics (NASDAQ:ATRA) vs. Amgen (NASDAQ:AMGN) Head to Head Analysis
www.americanbankingnews.com - February 10 at 10:32 AM |
| Zacks: Analysts Anticipate Atara Biotherapeutics Inc (NASDAQ:ATRA) to Announce -$1.30 EPS
www.americanbankingnews.com - February 6 at 10:16 PM |
| Atara Biotherapeutics Names Kristin Yarema as Chief Commercial Officer
finance.yahoo.com - February 5 at 8:40 AM |
| Head to Head Review: Atara Biotherapeutics (NASDAQ:ATRA) vs. Surface Oncology (NASDAQ:SURF)
www.americanbankingnews.com - February 3 at 12:55 PM |
| Atara Biotherapeutics Inc (NASDAQ:ATRA) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - February 1 at 11:52 AM |
| 5 Beaten-Down Biotech Stocks Set to Rebound in 2020
finance.yahoo.com - December 18 at 8:59 AM |
| Hedge Funds Have Never Been More Bullish On Atara Biotherapeutics Inc (ATRA)
finance.yahoo.com - December 11 at 11:28 PM |
 | Atara Biotherapeutics (ATRA) Presents At 2019 ASH Annual Meeting - Slideshow
seekingalpha.com - December 11 at 1:23 PM |
| Atara Biotherapeutics Reports Updated Long-Term Clinical Results from a Tab-cel® Multicenter Expanded Access Protocol (EAP) Study for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) at the 61st American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 9 at 10:52 AM |
| Atara Biotherapeutics to Participate at Evercore ISI Second Annual HealthCONx Conference
finance.yahoo.com - November 26 at 7:31 PM |
| Turnaround In Progress: Key Takeaways From Atara Biotherapeutics' Q3 Earnings Call
seekingalpha.com - November 14 at 1:54 PM |
 | Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why
www.nasdaq.com - November 12 at 1:53 PM |
| Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why
finance.yahoo.com - November 12 at 1:53 PM |
| Edited Transcript of ATRA earnings conference call or presentation 7-Nov-19 1:00pm GMT
finance.yahoo.com - November 8 at 9:12 AM |
 | Atara Biotherapeutics Inc (ATRA) Q3 2019 Earnings Call Transcript
www.fool.com - November 8 at 7:56 AM |
| Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress
finance.yahoo.com - November 7 at 7:54 AM |
| Atara Biotherapeutics to Present Tab-cel® Long-Term Clinical Outcomes from a Multicenter Expanded Access Protocol (EAP) Study for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) at the 61st American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - November 6 at 9:38 AM |
| Atara Biotherapeutics to Announce Third Quarter 2019 Operational Progress and Financial Results on Thursday, November 7, 2019
finance.yahoo.com - October 30 at 5:34 PM |
| Atara Biotherapeutics (ATRA) Presents at Cell & Gene Meeting On The Mesa - Slideshow
seekingalpha.com - October 3 at 9:18 PM |
| Atara Biotherapeutics: Current Price Presents Enticing Opportunities
seekingalpha.com - October 2 at 11:23 AM |
| Atara Biotherapeutics Stock Falls After Goldman Downgrade
finance.yahoo.com - September 27 at 3:08 PM |
| ATRA Stock Hits Five-Year Low on Goldman Bear Note
finance.yahoo.com - September 27 at 3:08 PM |
| Is Atara Biotherapeutics (NASDAQ:ATRA) In A Good Position To Invest In Growth?
finance.yahoo.com - September 26 at 3:25 PM |
 | ATRA.O - Atara Biotherapeutics Inc Profile | Reuters
www.reuters.com - September 25 at 8:32 PM |
| 3 Biotech Stocks Surging on Positive Results
finance.yahoo.com - September 23 at 7:15 AM |
| 3 Biotech Stocks Surging on Positive Results
finance.yahoo.com - September 23 at 7:15 AM |
 | Atara Biotherapeutics Reports Early Findings of...
www.benzinga.com - September 13 at 5:29 PM |
| Atara T-cell therapy shows encouraging action in early-stage MS study
seekingalpha.com - September 13 at 5:29 PM |
| Atara Biotherapeutics to Present Initial Efficacy and Additional Safety Results from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019
finance.yahoo.com - September 10 at 6:12 AM |
| Atara Biotherapeutics to Participate in Citi 14th Annual Biotech Conference
finance.yahoo.com - August 29 at 11:43 AM |
| Are Options Traders Betting on a Big Move in Atara (ATRA) Stock?
finance.yahoo.com - August 28 at 12:39 PM |
| Edited Transcript of ATRA earnings conference call or presentation 8-Aug-19 12:00pm GMT
finance.yahoo.com - August 12 at 12:58 PM |
 | BRIEF-Atara Biotherapeutics Reports Q2 Loss Per Share $1.60
www.msn.com - August 9 at 1:11 AM |
| Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 1:11 AM |
| Atara Biotherapeutics Announces Second Quarter 2019 Financial Results and Recent Operational Progress
finance.yahoo.com - August 8 at 11:24 AM |
| Atara Biotherapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on
www.nasdaq.com - August 1 at 11:44 PM |
| Atara Biotherapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Thursday, August 8, 2019
finance.yahoo.com - August 1 at 11:44 PM |
| Atara Bio pries $150M stock offering
seekingalpha.com - July 19 at 5:46 PM |
| Atara Bio prices $150M stock offering
seekingalpha.com - July 19 at 10:07 AM |
| Atara Biotherapeutics Announces Pricing of $150.0 Million Public Offering
finance.yahoo.com - July 19 at 10:07 AM |
| Atara launches $125M stock offering; shares down 2% after hours
seekingalpha.com - July 18 at 6:41 PM |
| Atara to initiate U.S. application for tab-cel in H2 2020
seekingalpha.com - July 16 at 9:07 AM |
| Atara Biotherapeutics Announces Plan to Initiate Tab-cel® FDA Biologics License Application Submission Next Year
finance.yahoo.com - July 16 at 9:07 AM |
| Why Atara Biotherapeutics Has Slumped in 2019
finance.yahoo.com - July 9 at 8:50 AM |
